|4Mar 7, 9:50 PM ET

AHMED NADIM 4

4 · Cullinan Oncology, Inc. · Filed Mar 7, 2022

Insider Transaction Report

Form 4
Period: 2022-03-05
AHMED NADIM
DirectorPresident and CEO
Transactions
  • Award

    Performance Stock Unit

    2022-03-05+215,000215,000 total
    Exp: 2025-03-05Common Stock (215,000 underlying)
Footnotes (1)
  • [F1]Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer. The performance stock units vest upon the Issuer's common stock achieving a specified price per share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION